Yahong Pharmaceutical announced its 2024 restricted stock incentive plan, with the planned number of restricted stocks to be granted to incentive recipients being 8.3201 million shares, accounting for approximately 1.46% of the total share capital of the company at the time of the announcement of this incentive plan draft. The grant this time is a one-time grant with no reserved portions.
亚虹医药：拟推832.01万股限制性股票激励计划
Yahong Medicine: Proposes to launch a restricted stock incentive plan of 8.3201 million shares.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated